Peer-review and openness

By Deepak Singh | Published: March 15, 2008

This is an interesting battle. Big Pharma vs. traditional peer-reviewed publishing.

A judge ruled that peer-reviewed documents requested by Pfizer could not be released by the New England Journal of Medicine (NEJM). Personally I believe peer-review should not be closed, although I am on the fence about the anonymity of reviewers.

Technorati Tags: , ,

This entry was posted in Pharma, Publishing. Bookmark the permalink. Post a comment or leave a trackback: Trackback URL.
blog comments powered by Disqus

  • Archives